It takes more than a pandemic to stop medical device companies merging.
Though orthopaedics companies have begun to recover from the second quarter’s horrors, it is clear that the third quarter belongs to the diagnostics specialists.
The new regulatory scheme poses problems – but also opportunities, in the shape of possible alignment with the US.
Welcome to the calm before the Covid-19 storm.
The Covid-19 pandemic has scythed vast sums from joint makers’ Q2 sales. But Medtronic’s summer earnings were better than those for its spring quarter.
The largest medtech companies have differing business development strategies, but tend to be on the same page on R&D spending.
Medtronic has had a poor quarter owing to the pandemic – but Zimmer’s has been even worse.
Covid-19 could mean Medtronic loses out to Abbott, its rival in the mitral valve space.